Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.22.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Collaboration revenue $ 41,998 $ 0
Operating expenses    
Research and development 154,090 159,109
Selling, general and administrative 31,052 32,680
Total operating expenses 185,142 191,789
Loss from operations (143,144) (191,789)
Other income (expense)    
Interest and other income 581 570
Change in fair value of derivative liabilities 65,810 0
Other expense (53) (44)
Loss before income taxes (76,806) (191,263)
Income tax expense (benefit) 2 (2,644)
Net loss $ (76,808) $ (188,619)
Basic net loss per share (in usd per share) $ (0.07) $ (0.39)
Diluted net loss per share (in usd per share) $ (0.07) $ (0.39)
Basic weighted-average shares outstanding (in shares) 1,126,147,810 483,555,367
Diluted weighted-average shares outstanding (in shares) 1,126,147,810 483,555,367